You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR NAFTIN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NAFTIN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01580891 ↗ Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis Completed Taro Pharmaceuticals USA Phase 1 2012-05-01 The objective of this study is to evaluate the efficacy and safety of the test formulation of Naftifine HCl Cream 1% (Taro Pharmaceuticals Inc.) as compared to the already marketed formulation Naftin® (Naftifine HCl) 1% Cream (Merz Pharmaceuticals) and placebo in patients with tinea pedis and to show the superiority of the active treatments over placebo when dosed once a day for 28 days.
NCT01885156 ↗ Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris Completed Merz North America, Inc. Phase 3 2013-08-01 To see how well Naftin 1% cream works when applied once daily to the affected area. The results will be compared to those using a placebo cream, which is a cream with no active ingredient. Safety will also be measured.
NCT01885156 ↗ Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris Completed Merz Pharmaceuticals, LLC Phase 3 2013-08-01 To see how well Naftin 1% cream works when applied once daily to the affected area. The results will be compared to those using a placebo cream, which is a cream with no active ingredient. Safety will also be measured.
NCT02132260 ↗ Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis Completed Taro Pharmaceuticals USA Phase 1 2013-08-01 The objective of this study is to compare the efficacy and safety of the test formulation of Naftifine Hydrochloride Cream 2% to Naftin® (Naftifine Hydrochloride) 2% Cream in a 6 week study in patients with tinea pedis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NAFTIN

Condition Name

Condition Name for NAFTIN
Intervention Trials
Tinea Pedis 5
Tinea Corporis 2
Tinea Cruris 2
Jock Itch 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NAFTIN
Intervention Trials
Tinea 8
Tinea Pedis 5
Tinea cruris 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NAFTIN

Trials by Country

Trials by Country for NAFTIN
Location Trials
United States 15
Dominican Republic 5
Honduras 3
Belize 1
Panama 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NAFTIN
Location Trials
Texas 3
Missouri 2
Florida 2
California 2
Oregon 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NAFTIN

Clinical Trial Phase

Clinical Trial Phase for NAFTIN
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 1 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NAFTIN
Clinical Trial Phase Trials
Completed 7
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NAFTIN

Sponsor Name

Sponsor Name for NAFTIN
Sponsor Trials
Taro Pharmaceuticals USA 3
Merz North America, Inc. 3
Merz Pharmaceuticals, LLC 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NAFTIN
Sponsor Trials
Industry 12
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.